Jeannie Joughin BSc, PhD

Jeannie Joughin has also held various scientific positions including Senior Research Scientist, Post-Doctorate and Senior Post-Doctorate positions in Australia at The Alfred Hospital, The Walter & Eliza Hall Institute, as well as internationally in Austria (University Clinic, Innsbruck) and Switzerland (Ludwig Institute for Cancer Research, Lausanne). Dr. Joughin began her career in the pharmaceutical industry in 1992 as a Clinical Research Manager with Bristol-Myers Squibb.
After managing local trials in oncology and cardiology, she moved into New Product Commercialisation as the interface between the medical and marketing departments. From there, Dr. Joughin worked in Brand Management. After successfully completing several marketing roles in the National Stroke Foundation, MediMark International and Mayne Pharma, Dr. Joughin joined CSL Biotherapies in 2005 as Director, Pharmaceuticals Marketing and In-licensing. She assumed responsibility for a portfolio of pharmaceutical products from several licensing partners in various therapeutic areas.
Her responsibilities included extending distribution agreements with current partners when appropriate and securing various new product distribution agreements. As Vice President, Business Development at CSL Behring Dr Joughin was responsible for managing business licensing arrangements and relationships. This involved close liaison with CSL Behring’s Commercial Development Team in the US, Germany and Switzerland.
Dr. Joughin joined Enable Injections as Vice President of Corporate Development in 2015 and now as Executive Vice President and Chief Commercial Officer she will support the CEO and Board with investment strategy and remains responsible for business development, strategic pharma partnerships, alliance management, as well as aiding in selection and prioritization of Enable Injections’ global portfolio.